Particularly apropos for Diabetes Awareness Month – a little DAA (diabetes attitude adjustment):
I was diagnosed with type 1 diabetes way back in 1994, when I was only 8 years old. Even as a child, certain words always stuck out to me whenever I was at the doctor’s office or read articles about diabetes.
In control.
Management.
Stable.
Sound familiar? For a long time, I’ve been told that diabetes was in my power to control,…
OK, big confession of the month (year?): I am happier without a CGM on. I am not proud of this, because I know I should be basking in the latest and greatest tools available to me, but it is the truth.
I do not like wearing the CGM sensor. I do not enjoy the skin irritations, the incessant beeping, the relative inaccuracies (lag time!), and the constant nagging obligation to keep track of yet another…
Today might be the spookiest day of the year, but have no fear, our favorite D-picks of the past month are here. Hey, that rhymed! Our friends in the DOC certainly make living with diabetes a little less scary, huh?
We’re still riding the wave of excitement following the epic Simonpalooza DOC meet-ups! Chris Snider chats with the man himself on this episode of the hit podcast, Just Talking.
Kim Vlasnik writes a great post…
The topic for this month’s Diabetes Social Media Advocacy (DSMA) blog carnival kind of made me do a double-take. Under the auspices of “what you should know about people living with diabetes,” the specific prompt question is:
What types of decisions and frequency of diabetes-related decisions do you make in any given day?
Uh… to quote a recent source here at the ‘Mine: what the frappuccino?
To me, living with diabetes is all about…
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »